[
  {
    "ts": null,
    "headline": "S&P 500 Gains and Losses Today: FICO Stock Falls as Federal Housing Official Questions Pricing",
    "summary": "The S&P 500 slipped 0.4% on Tuesday, May 20, snapping a six-day winning streak as investors' confidence on trade and inflation appeared to waver.",
    "url": "https://finnhub.io/api/news?id=6d3d4878d6b86989de705b247572f000ee4ce40c571b72d98450e959de61c333",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747775204,
      "headline": "S&P 500 Gains and Losses Today: FICO Stock Falls as Federal Housing Official Questions Pricing",
      "id": 134628755,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The S&P 500 slipped 0.4% on Tuesday, May 20, snapping a six-day winning streak as investors' confidence on trade and inflation appeared to waver.",
      "url": "https://finnhub.io/api/news?id=6d3d4878d6b86989de705b247572f000ee4ce40c571b72d98450e959de61c333"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals (NasdaqGS:REGN) Partners With Viz.ai For AI-Powered COPD Solutions",
    "summary": "Viz.ai's recent partnership with Sanofi and Regeneron Pharmaceuticals (NasdaqGS:REGN) brings AI technology to aid in the management of COPD patients, enhancing the healthcare process. Throughout the past month, Regeneron experienced a price increase of 6%, possibly boosted by this collaboration. This price move is closely aligned with broader market trends, which have seen a general uptick. Additional events, such as the clinical insights from Dupixent presentations and progress in oncology...",
    "url": "https://finnhub.io/api/news?id=984e737ae4ce83aae421f35789b5c71d52bd19346b1adf7b0309ceba472b6b13",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747762548,
      "headline": "Regeneron Pharmaceuticals (NasdaqGS:REGN) Partners With Viz.ai For AI-Powered COPD Solutions",
      "id": 134628756,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Viz.ai's recent partnership with Sanofi and Regeneron Pharmaceuticals (NasdaqGS:REGN) brings AI technology to aid in the management of COPD patients, enhancing the healthcare process. Throughout the past month, Regeneron experienced a price increase of 6%, possibly boosted by this collaboration. This price move is closely aligned with broader market trends, which have seen a general uptick. Additional events, such as the clinical insights from Dupixent presentations and progress in oncology...",
      "url": "https://finnhub.io/api/news?id=984e737ae4ce83aae421f35789b5c71d52bd19346b1adf7b0309ceba472b6b13"
    }
  },
  {
    "ts": null,
    "headline": "ATS 2025: Sanofi and Regeneron to launch new AIM4 trial for personalised asthma care",
    "summary": "All participants will initially undergo a run-in period on standardised medium-dose ICS/LABA to confirm persistent lack of control before randomisation.",
    "url": "https://finnhub.io/api/news?id=1085d99e99d441bf9c312bfa71b156d80fcf94533a8ffd9af8932966a185b655",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747757561,
      "headline": "ATS 2025: Sanofi and Regeneron to launch new AIM4 trial for personalised asthma care",
      "id": 134628757,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "All participants will initially undergo a run-in period on standardised medium-dose ICS/LABA to confirm persistent lack of control before randomisation.",
      "url": "https://finnhub.io/api/news?id=1085d99e99d441bf9c312bfa71b156d80fcf94533a8ffd9af8932966a185b655"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Regeneron Pharmaceuticals, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 11",
    "summary": "Presenter SpeechBrian Abrahams Capital Markets. Our next featured company, Regeneron has always been known for its R&D engine. And there's a lot more coming from their pipeline really over the next",
    "url": "https://finnhub.io/api/news?id=0e4103d8667b0f4fde427375a7eb48b5e9211fa7f69236689f7c1ea37417e608",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747756236,
      "headline": "Transcript : Regeneron Pharmaceuticals, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 11",
      "id": 134619405,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Presenter SpeechBrian Abrahams Capital Markets. Our next featured company, Regeneron has always been known for its R&D engine. And there's a lot more coming from their pipeline really over the next",
      "url": "https://finnhub.io/api/news?id=0e4103d8667b0f4fde427375a7eb48b5e9211fa7f69236689f7c1ea37417e608"
    }
  },
  {
    "ts": null,
    "headline": "Evercore says 23andMe buyout removes downside case for OraSure",
    "summary": "Evercore ISI believes Regeneron’s (REGN) acquisition of 23andMe for $256M announcement should remove the downside scenario where OraSure’s (OSUR) 23andMe contribution will be zero into perpetuity. Instead, the firm expects 23andMe should continue to be a “meaningful customer going forward” for OraSure. The company has previously disclosed that Regeneron is already an existing customer, which should bode well for a continued relationship between OraSure and 23andMe, the analyst tells investors in",
    "url": "https://finnhub.io/api/news?id=b13822201048a192b768e87bc89299d00a2b3f7f786aa084aba3c4e3b26fa0e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747755322,
      "headline": "Evercore says 23andMe buyout removes downside case for OraSure",
      "id": 134628758,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Evercore ISI believes Regeneron’s (REGN) acquisition of 23andMe for $256M announcement should remove the downside scenario where OraSure’s (OSUR) 23andMe contribution will be zero into perpetuity. Instead, the firm expects 23andMe should continue to be a “meaningful customer going forward” for OraSure. The company has previously disclosed that Regeneron is already an existing customer, which should bode well for a continued relationship between OraSure and 23andMe, the analyst tells investors in",
      "url": "https://finnhub.io/api/news?id=b13822201048a192b768e87bc89299d00a2b3f7f786aa084aba3c4e3b26fa0e1"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc. (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)",
    "summary": "Regeneron Pharmaceuticals, Inc. (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)",
    "url": "https://finnhub.io/api/news?id=08044f0ae9296cf162f2c1b1c26d7728bc838b5be6c0f9718cd48738f44387f9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747754653,
      "headline": "Regeneron Pharmaceuticals, Inc. (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)",
      "id": 134619355,
      "image": "",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=08044f0ae9296cf162f2c1b1c26d7728bc838b5be6c0f9718cd48738f44387f9"
    }
  },
  {
    "ts": null,
    "headline": "REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research",
    "summary": "Regeneron is set to acquire 23andMe assets for $256 million to boost genetic drug discovery. The transaction is expected to close by third-quarter 2025.",
    "url": "https://finnhub.io/api/news?id=741522b2834682853125965255f41af75d236dd6f36829d9b096a05469d39cee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747746660,
      "headline": "REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research",
      "id": 134628759,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron is set to acquire 23andMe assets for $256 million to boost genetic drug discovery. The transaction is expected to close by third-quarter 2025.",
      "url": "https://finnhub.io/api/news?id=741522b2834682853125965255f41af75d236dd6f36829d9b096a05469d39cee"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons Why Japan's Record Bond Yield Spike Matters",
    "summary": "Japan's bond yield surge hints at global market risks. See how it impacts U.S. Treasuries, the yen, and top investments like Toyota and Sony.",
    "url": "https://finnhub.io/api/news?id=7aa7a5385b694ca435ab7b1f935d5d6bd903354ebc7282f4d9c68563cb9c998b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747744205,
      "headline": "3 Reasons Why Japan's Record Bond Yield Spike Matters",
      "id": 134611311,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2161558032/image_2161558032.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Japan's bond yield surge hints at global market risks. See how it impacts U.S. Treasuries, the yen, and top investments like Toyota and Sony.",
      "url": "https://finnhub.io/api/news?id=7aa7a5385b694ca435ab7b1f935d5d6bd903354ebc7282f4d9c68563cb9c998b"
    }
  },
  {
    "ts": null,
    "headline": "Jamie Dimon’s Tariffs Warning Should Have Rocked Markets. Why He’s Being Ignored.",
    "summary": "Fed officials say debt downgrade complicates inflation outlook, Nvidia CEO discusses China chip ban, JPMorgan’s investor day, and more news to start your day.",
    "url": "https://finnhub.io/api/news?id=f3e865c8a731b42a54ef454419f541a267a408ca0e1075890873526941196f58",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747738080,
      "headline": "Jamie Dimon’s Tariffs Warning Should Have Rocked Markets. Why He’s Being Ignored.",
      "id": 134608909,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Fed officials say debt downgrade complicates inflation outlook, Nvidia CEO discusses China chip ban, JPMorgan’s investor day, and more news to start your day.",
      "url": "https://finnhub.io/api/news?id=f3e865c8a731b42a54ef454419f541a267a408ca0e1075890873526941196f58"
    }
  },
  {
    "ts": null,
    "headline": "Viz.Ai Announces Collaboration with Sanofi and Regeneron to Improve Management and Care of Chronic Obstructive Pulmonary Disease",
    "summary": "Viz.ai announced a multi-year partnership with Sanofi and Regeneron to deploy and evaluate an AI-powered workflow solution for chronic obstructive pulmonary disease . With support from Sanofi and...",
    "url": "https://finnhub.io/api/news?id=76093c4de3ac7c234c45c32d28ff6e98ea63344cebe22c7be001831568a4219c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747729221,
      "headline": "Viz.Ai Announces Collaboration with Sanofi and Regeneron to Improve Management and Care of Chronic Obstructive Pulmonary Disease",
      "id": 134608070,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "Viz.ai announced a multi-year partnership with Sanofi and Regeneron to deploy and evaluate an AI-powered workflow solution for chronic obstructive pulmonary disease . With support from Sanofi and...",
      "url": "https://finnhub.io/api/news?id=76093c4de3ac7c234c45c32d28ff6e98ea63344cebe22c7be001831568a4219c"
    }
  }
]